Sign in
8-K

Current Report

Niagen Bioscience, Inc. Filed Acc 0001628280-25-013681

Bylaws or fiscal year change · Regulation FD disclosure

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading cdxc-20250317.htm…